Exploration of lung mycobiome in the patients with non-small-cell lung cancer

被引:13
|
作者
Zhao, Yiming [1 ,2 ]
Yi, Junqi [1 ,3 ]
Xiang, Juanjuan [3 ,4 ,5 ]
Jia, Wei [6 ]
Chen, Anqi [1 ]
Chen, Liyu [2 ]
Zheng, Leliang [4 ,5 ]
Zhou, Wen [4 ,5 ]
Wu, Minghua [4 ,5 ]
Yu, Zheng [2 ]
Tang, Jingqun [1 ,3 ]
机构
[1] Cent South Univ, Xiangya Hosp 2, Dept Thorac Surg, Changsha, Hunan, Peoples R China
[2] Cent South Univ, Sch Basic Med Sci, Dept Microbiol, Changsha, Hunan, Peoples R China
[3] Hunan Key Lab Early Diag & Precise Treatment Lung, Changsha, Hunan, Peoples R China
[4] Cent South Univ, NHC Key Lab Carcinogenesis, Changsha, Hunan, Peoples R China
[5] Cent South Univ, Canc Res Inst, Sch Basic Med Sci, Chinese Minist Educ,Key Lab Carcinogenesis & Canc, Changsha, Hunan, Peoples R China
[6] Hong Kong Baptist Univ, Sch Chinese Med, Kowloon Tong, Peoples R China
基金
中国国家自然科学基金;
关键词
Non-small-cell lung cancer; Mycobiome; Alternaria arborescens; ACETALDEHYDE PRODUCTION; MICROBIOME; COMMUNITY; INFLAMMATION; INFECTIONS; IMMUNITY;
D O I
10.1186/s12866-023-02790-4
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
As the Human Microbiome Project (HMP) progresses, the relationship between microbes and human health has been receiving increasing attention. A growing number of reports support the correlation between cancer and microbes. However, most studies have focused on bacteria, rather than fungal communities. In this study, we studied the alteration in lung mycobiome in patients with non-small-cell lung cancer (NSCLC) using metagenomic sequencing and qPCR. The higher fungal diversity and more complex network were observed in the patients with NSCLC. In addition, Alternaria arborescens was found as the most relevant fungus to NSCLC, and the enrichment of it in cancerous tissue was also detected. This study proposes that the changes in fungal communities may be closely related to lung cancer, and provides insights into further exploration the relationship between lung cancer and fungi.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Osimertinib for non-small-cell Lung Cancer
    Alakus, Hakan
    Zander, Thomas
    Bruns, Christiane
    ONKOLOGE, 2018, 24 (02): : 174 - 176
  • [32] Adagrasib in Non-Small-Cell Lung Cancer
    Kotecha, Rupesh
    Sahgal, Arjun
    Mehta, Minesh P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (13): : 1238 - 1239
  • [33] Non-Small-Cell Lung Cancer: Then and Now
    Schiller, Joan H.
    Gandara, David R.
    Goss, Glenwood D.
    Vokes, Everett E.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (08) : 981 - 983
  • [34] Chemotherapy for non-small-cell lung cancer
    Satoh, H
    Sekizawa, K
    LANCET, 2001, 358 (9289): : 1270 - 1271
  • [35] Ifosfamide in non-small-cell lung cancer
    Rosell, R
    Martin, C
    Balaña, C
    ANNALS OF ONCOLOGY, 1999, 10 : 25 - 28
  • [36] Cetuximab in non-small-cell lung cancer
    Pirker, Robert
    Filipits, Martin
    TRANSLATIONAL LUNG CANCER RESEARCH, 2012, 1 (01) : 54 - 60
  • [37] Treatment of non-small-cell lung cancer
    Lavolé, A
    Blanchon, F
    Breton, JL
    Milleron, B
    REVUE DES MALADIES RESPIRATOIRES, 2004, 21 (01) : 175 - 178
  • [38] Bevacizumab for non-small-cell lung cancer
    Garassino, Marina Chiara
    Hollander, Lital
    Torri, Valter
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (13): : 1373 - 1373
  • [39] Oligometastatic Non-Small-Cell Lung Cancer
    Palma, David A.
    Videtic, Gregory M. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (02): : 223 - 226
  • [40] Effects of radiotherapy and chemotherapy on lung function in patients with non-small-cell lung cancer
    Gopal, R
    Starkschall, G
    Tucker, SL
    Cox, JDC
    Liao, ZX
    Hanus, M
    Kelly, JF
    Stevens, CW
    Komaki, R
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 56 (01): : 114 - 120